Immunogenicity and efficacy of recombinant subunit SARS-CoV-2 vaccine candidate in the Syrian hamster model

Immunogenicity and efficacy of recombinant subunit SARS-CoV-2 vaccine candidate in the Syrian hamster model

SARS-CoV-2 causes devastating impact on the human population and has become a major public health concern. The frequent emergence of SARS-CoV-2 variants of concern urges the development of safe and efficacious vaccine against SARS-CoV-2 variants. We developed a candidate vaccine Baiya SARS-CoV-2 Vax...

Full description

Bibliographic Details
Main Authors: Balamurugan Shanmugaraj, Narach Khorattanakulchai, Weena Paungpin, Yada Akkhawattanangkul, Suwimon Manopwisedjaroen, Arunee Thitithanyanont, Waranyoo Phoolcharoen
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Biotechnology Reports
Subjects:
COVID-19
SARS-CoV-2
Plant-produced subunit vaccine
Receptor binding domain
Protective immunity, Hamster challenge
Online Access:http://www.sciencedirect.com/science/article/pii/S2215017X22000765

Internet

http://www.sciencedirect.com/science/article/pii/S2215017X22000765

Similar Items